FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Thyreoidea Compositum Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Thyreoidea compositum® Injection Solution is indicated for stimulation of the defense system in thyroid dysfunction, connective tissue dysfunction and glandular dysfunction.
History
There is currently no drug history available for this drug.
Other Information
Injection Solution Ingredient Information: Each 2.2ml ampule contains: Sarcolacticum acidum 3X, Viscum album 3X, Colchicum autumnale 4X, Conium maculatum 4X, Galium aparine 4X, Fucus vesiculosus 6X, Sedum acre 6X, Sempervivum tectorum 6X, ATP Adenosine triphosphate 8X, Fumaricum acidum 8X, α-Ketoglutaricum acidum 8X, Malicum acidum 8X, Natrum oxalaceticum 8X, Pulsatilla 8X, Spongia tosta 8X, Thyreoidea suis 8X, Calcarea fuorica 10X, Funiculus umbilicalis suis 10X, Hepar suis 10X, Medulla ossis suis 10X, Splen suis 10X, Sulphur 10X, Thymus suis 10X, Cortisone aceticum 28X 22mcl each. Inactive ingredient: Sterile isotonic sodium chloride solution.
Sources
Thyreoidea Compositum Manufacturers
-
Heel Inc
Thyreoidea Compositum | Heel Inc
The dosage schedules listed below can be used as a general guide for the administration of Thyreoidea compositum® Injection Solution. Thyreoidea compositum® Injection Solution shows individual differences in clinical response. Therefore, the dosage for each patient should be individualized according to the patient’s response to therapy. Adults and children 7 years and older: in acute disorders, 1 ampule per day, otherwise 1 ampule, 1 to 3 times per week IM/SC/IV/ID.Children ages 2 to 6 receive ½ the adult dosage.
Discard unused solution.
Thyreoidea compositum® Injection Solution may be administered intravenously, intramuscularly, subcutaneously, or intradermally. The required dose of Thyreoidea compositum® Injection Solution is first withdrawn from the ampule into the syringe, and the syringe is then shaken briefy. Thyreoidea compositum® Injection Solution should be administered using a narrow gauge needle (e.g. 22 to 30 gauge). Note: Parental drug products like Thyreoidea compositum® Injection Solution should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Thyreoidea compositum® Injection Solution is a clear, colorless solution. Discolored solutions should be discarded.
Login To Your Free Account